Predominant pathogen competition and core microbiota divergence in chronic airway infection

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The ISME Journal

• Publication date

  2014-07-18

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/ismej.2014.124PMID 25036925PMCID PMC4274430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards unbiased bacterial community analysis in lower respiratory infections 1 2

  2014cited by this paper
• Three clinically distinct chronic pediatric airway infections share a common core microbiota.

  2014cited by this paper
• A novel microbiota stratification system predicts future exacerbations in bronchiectasis.

  2014cited by this paper
• Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.

  2013cited by this paper
• Economic Burden of Non-Cystic Fibrosis Bronchiectasis in the First Year after Diagnosis from A US Health Plan Perspective

  2013influential reference
• Novel concepts in nontypeable Haemophilus influenzae biofilm formation.

  2013influential reference
• Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases.

  2013cited by this paper
• Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

  2013cited by this paper
• Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

  2013cited by this paper
• A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation

  2013cited by this paper
• Interpreting infective microbiota: the importance of an ecological perspective.

  2013cited by this paper
• Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study.

  2013cited by this paper
• Interspecies Interaction between Pseudomonas aeruginosa and Other Microorganisms

  2013cited by this paper
• Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition

  2013cited by this paper
• Polymicrobial challenges to Koch’s postulates: Ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes

  2012cited by this paper
• Improvements in Cystic Fibrosis Lung Disease and Airway Inflammation Associated with Etanercept Therapy for Rheumatoid Arthritis: A Case Report

  2012cited by this paper
• Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience

  2012cited by this paper
• The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms.

  2012cited by this paper
• Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or “Old Hat”?

  2012cited by this paper
• Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin.

  2012cited by this paper
• Reducing bias in bacterial community analysis of lower respiratory infections

  2012cited by this paper
• MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects.

  2012influential reference
• Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations.

  2011cited by this paper
• Trends and Burden of Bronchiectasis-Associated Hospitalizations in the United States, 1993-2006

  2011cited by this paper
• The genus Prevotella in cystic fibrosis airways.

  2010cited by this paper
• Direct detection of Pseudomonas aeruginosa from patients with healthcare associated pneumonia by real time PCR.

  2010cited by this paper
• Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities

  2010cited by this paper
• Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.

  2010influential reference
• Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.

  2010cited by this paper
• Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients

  2010cited by this paper
• The role of anaerobic bacteria in chronic suppurative otitis media in children: implications for medical therapy.

  2008cited by this paper
• Polymicrobial Nature of Chronic Diabetic Foot Ulcer Biofilm Infections Determined Using Bacterial Tag Encoded FLX Amplicon Pyrosequencing (bTEFAP)

  2008cited by this paper
• Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

  2008cited by this paper
• Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.

  2007cited by this paper
• Aetiology in adult patients with bronchiectasis.

  2007cited by this paper
• Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates

  2006cited by this paper
• Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

  2005cited by this paper
• Prevalence and Economic Burden of Bronchiectasis

  2005influential reference
• Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling

  2004cited by this paper
• Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling

  2003cited by this paper
• Sputum induction

  2002cited by this paper
• Bronchiectasis in systemic diseases.

  1999cited by this paper
• The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis.

  1998cited by this paper
• Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.

  1996cited by this paper
• Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis.

  1981cited by this paper
• Lung function.

  1949cited by this paper
• Bronchiectasis

  1908cited by this paper

• Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study

  2026cites this paper
• Effects of erythromycin dosage on clinical outcomes in stable non-cystic fibrosis bronchiectasis: A randomized controlled trial

  2025cites this paper
• Determining factors of non-fibrocystic bronchiectasis in patients from southern Brazil: pilot study

  2025cites this paper
• Ecological patterns and processes of temporal turnover within lung infection microbiota

  2024cites this paper
• Perturbations in the airway microbiome are associated with type 2 asthma phenotype and severity.

  2024cites this paper
• Clinical epidemiology and impact of Haemophilus influenzae airway infections in adults with cystic fibrosis

  2024cites this paper
• Understanding the effects of Haemophilus influenzae colonization on bronchiectasis: a retrospective cohort study

  2024cites this paper
• Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD: A Pilot Study

  2024cites this paper
• T2-Low Asthma: A Discussed but Still Orphan Disease

  2023cites this paper
• The microbiology and pathogenesis of nonfermenting Gram-negative infections

  2023cites this paper
• Lower respiratory tract microbiome composition and community interactions in smokers

  2023cites this paper
• Gut microbiota axis: potential target of phytochemicals from plant-based foods

  2023cites this paper
• Interactions between the lung microbiome and host immunity in chronic obstructive pulmonary disease

  2023cites this paper
• Immunonutrition and SARS-CoV-2 Infection in Children with Obesity

  2022cites this paper
• Sub-Inhibitory Antibiotic Exposure and Virulence in Pseudomonas aeruginosa

  2021cites this paper
• Comparison of the airway microbiota in children with chronic suppurative lung disease

  2021cites this paper
• Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis.

  2021cites this paper
• Neutrophils in asthma: the good, the bad and the bacteria

  2021cites this paper
• Landscape Seroprevalence of Three Hemorrhagic Disease-Causing Viruses in a Wild Cervid

  2021cites this paper
• The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.

  2021cites this paper
• Title Geographic variation in the aetiology , epidemiology andmicrobiology of bronchiectasis

  2019cites this paper
• A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome

  2019cites this paper
• The microbiome in bronchiectasis

  2019cites this paper
• The involvement of McpB chemoreceptor from Pseudomonas aeruginosa PAO1 in virulence

  2019cites this paper
• Combating Biofilm and Quorum Sensing: A New Strategy to Fight Infections

  2019cites this paper
• Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis

  2018cites this paper
• Altered community compositions of Proteobacteria in adults with bronchiectasis

  2018cites this paper
• Sputum purulence-associated microbial community compositions in adults with bronchiectasis.

  2018cites this paper
• Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology

  2018cites this paper
• Population dynamics and transcriptomic responses of Pseudomonas aeruginosa in a complex laboratory microbial community

  2018cites this paper
• RELATIONSHIPS BETWEEN BACTERIA, EXACERBATIONS, AND HOSPITALIZATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2018cites this paper
• The Human Respiratory Microbiome: Implications and Impact

  2018cites this paper
• Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis

  2018cites this paper
• Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease

  2018cites this paper
• A signature of tree health? Shifts in the microbiome and the ecological drivers of horse chestnut bleeding canker disease.

  2017cites this paper
• The impact of persistent bacterial bronchitis on the pulmonary microbiome of children

  2017cites this paper
• Microbiomes in respiratory health and disease: An Asia‐Pacific perspective

  2017cites this paper
• Bacterial community structure transformed after thermophilically composting human waste in Haiti

  2017cites this paper
• Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress.

  2017cites this paper
• REGULATION OF NONTYPEABLE HAEMOPHILUS INFLUENZAE-INDUCED INFLAMMATION IN UPPER RESPIRATORY TRACT

  2017cites this paper
• The lung microbiome.

  2017cites this paper
• Bronchiectasis and Aspergillus: How are they linked?

  2017cites this paper
• FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis

  2016cites this paper
• Precision respiratory medicine and the microbiome.

  2016cites this paper
• Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis.

  2016cites this paper
• Next Generation Sequencing and the Microbiome of Chronic Rhinosinusitis

  2016cites this paper
• Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers

  2016cites this paper
• The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.

  2016cites this paper
• Microbial Dysbiosis after Lung Transplantation.

  2016cites this paper
• Bronchiectasis: What We Don't Know Yet But Should

  2016cites this paper
• State of the art review: management of bronchiectasis in adults

  2015cites this paper
• Host–microbe interactions in distal airways: relevance to chronic airway diseases

  2015cites this paper
• Actualités dans la prise en charge de l’infection respiratoire par Pseudomonas aeruginosa et les thérapeutiques inhalées

  2015cites this paper
• The microbiome of otitis media with effusion in Indigenous Australian children.

  2015cites this paper
• The Gut-Lung Axis in Respiratory Disease.

  2015cites this paper
• Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.

  2015cites this paper
• Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization

  2015cites this paper
• Management of bronchiectasis in adults

  2015cites this paper
• Inhaled Antibiotics in Cystic Fibrosis (CF) and Non-CF Bronchiectasis

  2015cites this paper
• Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae

  2014cites this paper